Mesoblast Reports Strong Financial Position and Substantial Operational Progress For the Period Ended March 31, 2020


You May Also Like

Inovio Announces Leadership Appointments

PLYMOUTH MEETING, Pa., June 28, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ:INO) today ...

BeyondSpring to Present at Upcoming Investor Conferences

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global clinical-stage ...